Jove
Visualize
Contact Us

Related Experiment Videos

Therapeutic advances in ulcerative colitis.

S Hak, G Dukes

    The Journal of Practical Nursing
    |September 1, 1992
    PubMed
    Summary

    Ulcerative colitis treatment requires personalized approaches. Newer aminosalicylate formulations, particularly rectal and oral mesalamine, show promise over older sulfasalazine options for managing this chronic inflammatory bowel disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Caries Incidence Is Associated with Wasting among Cambodian Children.

    Journal of dental research·2022
    Same author

    Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.

    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2021
    Same author

    Good enough for Iganga?

    The International journal of risk & safety in medicine·2013
    Same author

    Risk management and good medicine.

    The International journal of risk & safety in medicine·2013
    Same author

    Care and cholesterol.

    The International journal of risk & safety in medicine·2013
    Same author

    Affordably priced new drugs for poor populations: Approaches for a global solution.

    The International journal of risk & safety in medicine·2012
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Gastroenterology
    • Internal Medicine
    • Pharmacology

    Background:

    • Ulcerative colitis (UC) is a chronic inflammatory condition requiring tailored treatment strategies.
    • Disease management necessitates adaptation based on symptoms, location, severity, and chronicity.
    • Treatment plans must evolve as the disease stage progresses.

    Purpose of the Study:

    • To review current therapeutic agents for ulcerative colitis.
    • To evaluate the efficacy of aminosalicylates and corticosteroids in UC management.
    • To compare newer mesalamine formulations with traditional sulfasalazine.

    Main Methods:

    • Literature review of existing studies on ulcerative colitis therapies.
    • Analysis of clinical data on aminosalicylate and corticosteroid efficacy.
    • Comparative assessment of different mesalamine delivery methods (oral vs. rectal) and sulfasalazine.

    Main Results:

    • Systemic and rectal aminosalicylates, alongside corticosteroids, are primary therapeutic agents for UC.
    • Rectal and oral mesalamine formulations demonstrate superior efficacy compared to sulfasalazine.
    • Individualized therapy is crucial due to the variable nature of ulcerative colitis.

    Conclusions:

    • Aminosalicylates, particularly mesalamine, are key in ulcerative colitis treatment.
    • Ongoing research will define the role of newer agents in medical and surgical management of UC.
    • Personalized treatment plans are essential for effective ulcerative colitis management.

    Related Experiment Videos